Literature DB >> 33281117

DOK3 is involved in microglial cell activation in neuropathic pain by interacting with GPR84.

Wen-Shuang Gao1, Yu-Juan Qu1, Juan Huai1, Hui Wei1, Yang Zhang1, Shou-Wei Yue1.   

Abstract

Adaptor molecule downstream of kinase-3 (DOK3) is a vital regulator of innate immune responses in macrophages and B cells, and G-protein-coupled receptor 84 (GPR84) is significant in mediating the biosynthesis and maintenance of inflammatory mediators that are induced by neuropathic pain in microglia. In the present study, we determined the role of DOK3 in activating microglia-induced neuropathic pain and investigated the underlying mechanisms associated with GPR84. We found that knockdown of DOK3 in microglial cells dramatically reduced the levels of inflammatory factors, and we uncovered a physical association between DOK3 and GPR84 in the induction of inflammatory responses. We also observed that neuropathic pain and inflammatory responses induced by chronic constriction injury (CCI) of the sciatic nerve or intrathecal injection of a GPR84 agonist were compromised in DOK3-/- mice in vivo. Finally, enforced expression of DOK3 provoked inflammatory responses, and administration of pregabalin relieved neuropathic pain via inhibition of DOK3 expression. In conclusion, DOK3 induced neuropathic pain in mice by interacting with GPR84 in microglia. We hypothesize that targeting the adaptor protein DOK3 may open new avenues for pharmaceutical approaches to the alleviation of neuropathic pain in the spinal cord.

Entities:  

Keywords:  DOK3; GPR84; microglia; neuropathic pain; pregabalin

Mesh:

Substances:

Year:  2020        PMID: 33281117      PMCID: PMC7835011          DOI: 10.18632/aging.202144

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  47 in total

1.  Antinociceptive effect of pregabalin in septic shock-induced rectal hypersensitivity in rats.

Authors:  H Eutamene; A M Coelho; V Theodorou; M Toulouse; M Chovet; A Doherty; J Fioramonti; L Bueno
Journal:  J Pharmacol Exp Ther       Date:  2000-10       Impact factor: 4.030

2.  What goes up must come down: A tripartite Dok-3/Grb2/SHIP1 inhibitory module limits BCR signaling.

Authors:  Michael Reth; Michael R Gold
Journal:  Eur J Immunol       Date:  2016-11       Impact factor: 5.532

3.  GPR84 deficiency reduces microgliosis, but accelerates dendritic degeneration and cognitive decline in a mouse model of Alzheimer's disease.

Authors:  Julie Audoy-Rémus; Lusine Bozoyan; Aline Dumas; Mohammed Filali; Cynthia Lecours; Steve Lacroix; Serge Rivest; Marie-Eve Tremblay; Luc Vallières
Journal:  Brain Behav Immun       Date:  2015-01-28       Impact factor: 7.217

4.  DOK3 is required for IFN-β production by enabling TRAF3/TBK1 complex formation and IRF3 activation.

Authors:  Susana Soo-Yeon Kim; Koon-Guan Lee; Ching-Siang Chin; Say-Kong Ng; Natasha Ann Pereira; Shengli Xu; Kong-Peng Lam
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

5.  Gene therapy by lentivirus-mediated RNA interference targeting extracellular-regulated kinase alleviates neuropathic pain in vivo.

Authors:  Lei Jia; Yang Zhang; Yu-Juan Qu; Juan Huai; Hui Wei; Shou-Wei Yue
Journal:  J Cell Biochem       Date:  2018-11-13       Impact factor: 4.429

6.  miRNA 146a-5p-loaded poly(d,l-lactic-co-glycolic acid) nanoparticles impair pain behaviors by inhibiting multiple inflammatory pathways in microglia.

Authors:  Thuỳ Linh Phạm; Yuhua Yin; Hyeok Hee Kwon; Nara Shin; Song I Kim; Hyewon Park; Juhee Shin; Hyo Jung Shin; Jeong-Ah Hwang; Hee-Jung Song; Sang Ryong Kim; Joo Hyoung Lee; Patrick T J Hwang; Ho-Wook Jun; Dong Woon Kim
Journal:  Nanomedicine (Lond)       Date:  2020-04-15       Impact factor: 5.307

7.  Toll-like receptor 2 mediates peripheral nerve injury-induced NADPH oxidase 2 expression in spinal cord microglia.

Authors:  Hyoungsub Lim; Donghoon Kim; Sung Joong Lee
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

8.  G protein-coupled receptor 84, a microglia-associated protein expressed in neuroinflammatory conditions.

Authors:  Caroline Bouchard; Julie Pagé; Andréanne Bédard; Pierrot Tremblay; Luc Vallières
Journal:  Glia       Date:  2007-06       Impact factor: 7.452

9.  TRAF6-mediated degradation of DOK3 is required for production of IL-6 and TNFα in TLR9 signaling.

Authors:  Ning Liu; Bin Tang; Pan Wei; Wanchun Sun; Shuangxi Wang; Qisheng Peng
Journal:  Mol Immunol       Date:  2015-11-06       Impact factor: 4.407

10.  Vitamin B6 inhibits macrophage activation to prevent lipopolysaccharide-induced acute pneumonia in mice.

Authors:  Mei-Rong Shan; Sheng-Nan Zhou; Chang-Ning Fu; Jia-Wen Song; Xue-Qing Wang; Wen-Wu Bai; Peng Li; Ping Song; Mo-Li Zhu; Zhi-Min Ma; Zhan Liu; Jian Xu; Bo Dong; Chao Liu; Tao Guo; Cheng Zhang; Shuang-Xi Wang
Journal:  J Cell Mol Med       Date:  2020-01-22       Impact factor: 5.310

View more
  3 in total

1.  RIP3 Inhibition ameliorates chronic constriction injury-induced neuropathic pain by suppressing JNK signaling.

Authors:  Na He; Yu-Juan Qu; Dan-Yang Li; Shou-Wei Yue
Journal:  Aging (Albany NY)       Date:  2021-11-12       Impact factor: 5.682

Review 2.  Emerging roles of circular RNAs in neuropathic pain.

Authors:  Derong Xu; Xuexiao Ma; Chong Sun; Jialuo Han; Chuanli Zhou; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2021-10-08       Impact factor: 6.831

3.  Alzheimer's disease: insights from a network medicine perspective.

Authors:  Federica Conte; Paola Paci
Journal:  Sci Rep       Date:  2022-10-07       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.